Letter to the Editor
British Journal of Cancer (2007) 96, 180–181. doi:10.1038/sj.bjc.6603542 www.bjcancer.com
Published online 9 January 2007
Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient
T Negri1, P Casieri1, F Miselli1, M Orsenigo1, C Piacenza1, S Stacchiotti2, P Bidoli2, P G Casali2, M A Pierotti3, E Tamborini1 and S Pilotti1
- 1Laboratory of Experimental Molecular Pathology, IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1 20133 Milan, Italy
- 2Department of Medical Oncology, IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1 20133 Milan, Italy
- 3IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1 20133 Milan, Italy
Correspondence: Dr S Pilotti, E-mail: silvana.pilotti@istitutotumori.mi.it
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene Original Article
Oncogene Scientific Correspondence
Modern Pathology Original Article
Cutaneous Melanoma in Childhood and Adolescence Shows Frequent Loss of INK4A and Gain of KIT
Journal of Investigative Dermatology Original Article
Modern Pathology Original Article
